340Banter Podcast

Recorded live at the RWC 340B Grantee Conference in Houston, this episode of 340Banter features Michael Thompson, Managing Director for RWC 340B, for a conversation about how the conference has grown and evolved alongside the grantee community. Michael discusses how attendee feedback helps shape conference programming, how RWC 340B has expanded its reach to more grantee types, and the work behind...

Recorded live at the RWC 340B Grantee Conference in Houston, this episode of 340Banter examines the growing operational impact of manufacturer policies requiring claims data from entity-owned pharmacies. The conversation covers the challenges pharmacies face in extracting and formatting data, the importance of aligning the correct 340B ID with wholesaler purchasing accounts, and how pharmacies can...

Manufacturer Good Faith Inquiries (GFIs) are becoming increasingly important for 340B covered entities. But what triggers a GFI, and how should an FQHC respond? In this episode, the FQHC 340B Compliance team discusses the rise in Manufacturer Good Faith Inquiries and how increased access to 340B transaction data is allowing manufacturers to identify potential compliance concerns. The conversation...

In this episode of 340Banter, we sit down with Lisa Nelson, Chief Pharmacy Officer at Unity Care Northwest, to discuss the advocacy behind Washington’s Contract Pharmacy Protection Bill. Lisa shares how health centers, pharmacy associations, public hospital partners, and other advocates built a coalition to move the legislation forward during Washington’s 60-day legislative session. We also discus...

In this episode of 340Banter, we sit down with Christina Harbison, Senior Clinical Pharmacist at Prism Health North Texas, to discuss how the organization grew its long-acting injectable (LAI) program from 18 patients to approximately 700. Christina shares how Prism Health North Texas has navigated medication acquisition, prescription and medical benefits, buy-and-bill, prior authorizations, and p...

In this episode of 340Banter, we sit down with Angela Sorber, Director of Pharmacy Service Line at Nevada Health Centers, to discuss the realities of managing 340B pharmacy operations across multiple in-house pharmacy locations. Angela shares how her team adapts to the unique needs of different patient populations while maintaining consistent operations across the organization. We discuss the impo...

In this episode of 340Banter, we break down one of the biggest operational challenges facing health centers today: documenting clinic-administered drugs. For many organizations, paper logs and spreadsheets are no longer enough to keep up with evolving manufacturer requirements. As the industry moves toward rebate models and medical claims data submissions, gaps in documentation and billing could p...

How often do HRSA Operational Site Visits (OSVs) occur, and what exactly are reviewers looking for during these important compliance assessments? In this episode of 340Banter, Chelsea Violette and Logan Yoho discuss recent updates to HRSA's Operational Site Visit (OSV) Protocol and how the changes help clarify expectations for health centers navigating compliance requirements. A key focus of the c...

What do all those 340B financial reports actually mean, and how can organizations make sense of them when every vendor seems to report data differently? In this episode of 340Banter, Chelsea Violette and Logan Yoho sit down with Michael Gonzalez, Founder of FQHC 340B Compliance, to unpack one of the biggest operational challenges facing 340B Programs today: navigating non-standardized financial re...

What exactly is an Annual Single Audit, and why does it matter for organizations participating in the 340B Drug Pricing Program? In this episode of 340Banter, Chelsea Violette and Logan Yoho sit down with Michael Gonzalez, Founder of FQHC 340B Compliance, to break down the essentials of the Single Audit process and its critical connection to pharmacy operations within 340B Programs. Whether you're...

Donavan received his Bachelor’s degree in pharmacy from the University of Utah College of Pharmacy in 1995. His past work experience includes being a retail pharmacist at Albertsons, a Director of Pharmacy at Gunnison Valley Hospital, and a Director of Pharmacy at Central Valley Medical Center. While at Gunnison Valley Hospital, he sat on the Pharmacy and Therapeutics committee and was an active m...

On this episode of 340Banter, Donovan Smith, CEO of Wayne Community Health Centers, details the real-world impact of the IRA’s Maximum Fair Price (MFP) implementation. He explains how claims are being misattributed to 340B, the challenges of a dual inventory model in a remote pharmacy, the financial strain from denied rebates and low dispensing fees, and the risks to patient access. Donovan also d...

In this episode, we explore a powerful and timely topic: How to reteach yourself how to learn. Whether you’re returning to school, starting a new career, rebuilding confidence, or simply feeling stuck, learning as an adult can feel very different than it did before. The good news? Learning is a skill, and it can be rebuilt. This conversation dives into the mindset shifts, habits, and strategies th...

In this episode of the 340Banter Podcast, co-hosts Chelsea Violette and Logan Yoho take a closer look at MFP Drugs, the first prescription medications selected for Maximum Fair Price (MFP) under Medicare’s new drug pricing authority. With Medicare now negotiating prices for some of the most widely used and expensive drugs in the U.S., the spotlight is on how these MFP drug selections will affect p...

In this episode of the 340Banter Podcast, co-hosts Chelsea Violette and Logan Yoho break down the latest on Maximum Fair Price (MFP) under the Inflation Reduction Act and ask the big question: How’s it going so far? As Medicare drug price negotiations move from policy theory to real-world implementation, stakeholders across the healthcare system are feeling the impact. Chelsea and Logan unpack wha...

Running a clinical pharmacy under 340B isn’t just about discounts; it’s about delivering high-quality care and maximizing the program's value. Jamie Kim shares strategies for using 340B savings to expand clinical pharmacy services, improve patient access, and enhance outcomes while remaining compliant. This episode is especially helpful for administrators and pharmacy directors looking to get the...

Accurate UDS reporting is crucial for health centers, but many overlook the role of pharmacy operations and 340B activity in this process. Matthew Krah walks listeners through key considerations for integrating pharmacy and 340B data into Uniform Data System (UDS) reporting. Learn how to ensure your 340B-related prescriptions and savings are properly documented, and avoid common reporting mistakes...

Specialty pharmacies are playing a growing role under 340B, but with that growth comes complexity. Jamie Kim explains how 340B impacts specialty drug distribution, what 340B-eligible health centers need to know before partnering, and where the biggest compliance and financial risks lie. Whether you’re managing a contract pharmacy or overseeing 340B strategy in your organization, this episode offer...

Join us as Matt Krah walks through best practices for maintaining a 340B Third-Party Administrator (TPA) program. We cover how TPAs help ensure compliance, manage claims, and streamline contract-pharmacy networks, as well as key red flags to watch out for. If you run or support a 340B covered entity, this episode gives you practical insights to avoid pitfalls and stay audit-ready.

How is provider reporting evolving in today’s 340B environment? Recorded live from the conference floor, this episode of 340Banter brings together co-host Logan Yoho and guest co-host Felicity Homsted to unpack the shifting landscape that covered entities are facing. From new reporting requirements to the impact of technology and data management, this discussion explores the key changes leaders ne...

How can milestone moments spark meaningful advocacy and community engagement in the 340B space? Recorded live from the conference floor, this episode of 340Banter features Brenda Reitz, Pharmacy Director at Family Health Services, with co-host Logan Yoho and guest host Felicity Homsted. Brenda shares how her organization’s 20th anniversary celebration became more than a milestone—it became a catal...

What surprises are covered entities facing in HRSA-approved manufacturer audits today? Recorded live from the conference floor, this episode of 340Banter features Madeline Wallack, Founder of Rx|X Consulting & Avanti340B, alongside co-host Logan Yoho and guest host Felicity Homsted. Together, they share real-world insights from the frontlines of manufacturer audits and discuss how FQHCs and ot...

What does the new 340B Rebate Model Pilot mean for FQHCs and covered entities navigating today’s 340B landscape? In this episode of 340Banter, co-host Logan Yoho and guest host Felicity Homsted break down the details of this evolving initiative and what it could mean for compliance, program savings, and manufacturer relationships. From understanding the intent of the pilot to anticipating potentia...

How can you stay compliant while managing the growing complexity of 340B programs? In Episode 15 of 340Banter, Charnay Ingram and LaNika Ellis share proven oversight strategies that keep their programs running smoothly and audit-ready. From tracking changes to engaging internal stakeholders, this episode offers practical, scalable tips that every 340B leader needs to hear—whether you're overseeing...

What’s driving the surge in state contract pharmacy protection laws—and how does a 340B-related bill actually become a law? In Episode 14 of 340Banter, co-hosts Chelsea Violette and Logan Yoho break it all down with clarity, insight, and real-world relevance. Whether you're advocating for change, tracking legislation, or trying to understand your state’s protections, this episode gives you the fou...